Foley & Lardner LLP partner Louis Lehot is quoted in the Law360 article, “Attys Hopeful For Deals Pickup As JPMorgan Event Kicks Off,” offering perspective ahead of the annual J.P. Morgan Healthcare Conference in San Francisco on capital-raising and mergers and acquisitions, in particular for the health care and life sciences sector.
“What a life sciences investor needs is a risk-on environment and a good portfolio of companies that have molecules that can go to market in the near term,” explained Lehot. “And that means they can be an acquisition target.”
(Subscription required)
People
Related News
December 3, 2025
In the News
Vanessa Miller Assesses Automotive Tariff Impact on Trucking Industry
Foley & Lardner LLP partner Vanessa Miller discussed the ongoing disruption in trucking demand resulting from recent automotive tariffs in the TruckingDive article, “Tariffs swing volumes up and down for auto haulers.”
November 28, 2025
In the News
Cassandra Aubert Assesses Circuit Split on SEC Disgorgement Authority
Foley & Lardner LLP associate Cassandra Aubert commented on the growing scrutiny around the U.S. Security and Exchange Commission's disgorgement authority in the Bloomberg Law's article, “SEC Power to Recoup Illegal Profits at Risk as Justices Eye Case."
November 25, 2025
In the News
Gregory Husisian Analyzes SCOTUS Tariff Case
Foley & Lardner LLP partner Gregory Husisian appeared in a SupplyChainBrain video interview to discuss the U.S. Supreme Court case on the Trump administration’s imposition of tariffs under the International Emergency Economic Powers Act (IEEPA) and options the administration can consider should the court strike them down.